Literature DB >> 20101746

Long-term mortality in nonalcoholic fatty liver disease: is liver histology of any prognostic significance?

Paul Angulo.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20101746      PMCID： PMC2945376          DOI： 10.1002/hep.23521

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  13 in total

1.  The natural history of nonalcoholic fatty liver disease: a population-based cohort study.

Authors:  Leon A Adams; James F Lymp; Jenny St Sauver; Schuyler O Sanderson; Keith D Lindor; Ariel Feldstein; Paul Angulo
Journal:  Gastroenterology       Date:  2005-07       Impact factor: 22.682

2.  Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C.

Authors:  Arun J Sanyal; Colin Banas; Carol Sargeant; Velimir A Luketic; Richard K Sterling; Richard T Stravitz; Mitchell L Shiffman; Douglas Heuman; Adrian Coterrell; Robert A Fisher; Melissa J Contos; Alan S Mills
Journal:  Hepatology       Date:  2006-04       Impact factor: 17.425

3.  Long-term follow-up of patients with NAFLD and elevated liver enzymes.

Authors:  Mattias Ekstedt; Lennart E Franzén; Ulrik L Mathiesen; Lars Thorelius; Marika Holmqvist; Göran Bodemar; Stergios Kechagias
Journal:  Hepatology       Date:  2006-10       Impact factor: 17.425

4.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease.

Authors:  David E Kleiner; Elizabeth M Brunt; Mark Van Natta; Cynthia Behling; Melissa J Contos; Oscar W Cummings; Linda D Ferrell; Yao-Chang Liu; Michael S Torbenson; Aynur Unalp-Arida; Matthew Yeh; Arthur J McCullough; Arun J Sanyal
Journal:  Hepatology       Date:  2005-06       Impact factor: 17.425

5.  Decreased survival of subjects with elevated liver function tests during a 28-year follow-up.

Authors:  Cecilia Söderberg; Per Stål; Johan Askling; Hans Glaumann; Greger Lindberg; Joel Marmur; Rolf Hultcrantz
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425

6.  Long-term follow-up of patients with nonalcoholic fatty liver.

Authors:  Nila Rafiq; Chunhong Bai; Yun Fang; Manirath Srishord; Arthur McCullough; Terry Gramlich; Zobair M Younossi
Journal:  Clin Gastroenterol Hepatol       Date:  2008-11-07       Impact factor: 11.382

7.  Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C.

Authors:  Jason M Hui; James G Kench; Shivakumar Chitturi; Archana Sud; Geoffrey C Farrell; Karen Byth; Pauline Hall; Mahbub Khan; Jacob George
Journal:  Hepatology       Date:  2003-08       Impact factor: 17.425

8.  Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C.

Authors:  Satoru Yatsuji; Etsuko Hashimoto; Maki Tobari; Makiko Taniai; Katsutoshi Tokushige; Keiko Shiratori
Journal:  J Gastroenterol Hepatol       Date:  2008-11-20       Impact factor: 4.029

9.  Final results of a long-term, clinical follow-up in fatty liver patients.

Authors:  Sanne Dam-Larsen; Ulrik Becker; Maria-Benedicte Franzmann; Klaus Larsen; Per Christoffersen; Flemming Bendtsen
Journal:  Scand J Gastroenterol       Date:  2009       Impact factor: 2.423

10.  The natural history of nonalcoholic fatty liver: a follow-up study.

Authors:  M R Teli; O F James; A D Burt; M K Bennett; C P Day
Journal:  Hepatology       Date:  1995-12       Impact factor: 17.425
View more
  85 in total

1.  A case of cryoglobulinemia associated with nonalcoholic steatohepatitis.

Authors:  David Giangreco; Steven J Scaglione; Stanley Martin Cohen; Rodney Tehrani
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-04

2.  Noninvasive Diagnosis of NASH and Liver Fibrosis Within the Spectrum of NAFLD.

Authors:  Naim Alkhouri; Arthur J McCullough
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-10

Review 3.  Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future.

Authors:  Emer Fitzpatrick; Anil Dhawan
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

4.  Beneficial effects of mineralocorticoid receptor blockade in experimental non-alcoholic steatohepatitis.

Authors:  Margarita Pizarro; Nancy Solís; Pablo Quintero; Francisco Barrera; Daniel Cabrera; Pamela Rojas-de Santiago; Juan P Arab; Oslando Padilla; Juan C Roa; Han Moshage; Alexander Wree; Eugenia Inzaugarat; Ariel E Feldstein; Carlos E Fardella; Rene Baudrand; Arnoldo Riquelme; Marco Arrese
Journal:  Liver Int       Date:  2015-02-23       Impact factor: 5.828

Review 5.  Non-alcoholic fatty liver disease and liver transplantation: outcomes and advances.

Authors:  Adnan Said
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

6.  Moro orange juice prevents fatty liver in mice.

Authors:  Federico Salamone; Giovanni Li Volti; Lucilla Titta; Lidia Puzzo; Ignazio Barbagallo; Francesco La Delia; Shira Zelber-Sagi; Michele Malaguarnera; Pier Giuseppe Pelicci; Marco Giorgio; Fabio Galvano
Journal:  World J Gastroenterol       Date:  2012-08-07       Impact factor: 5.742

7.  Is there any progress in the treatment of non-alcoholic fatty liver disease?

Authors:  Emmanuel A Tsochatzis; George V Papatheodoridis
Journal:  World J Gastrointest Pharmacol Ther       Date:  2011-02-06

8.  Hepatic fibrosis developing in morbid obesity independent of steatohepatitis: new mechanism or the Rube Goldberg machine?

Authors:  Eric R Kallwitz
Journal:  Hepatol Int       Date:  2012-03-11       Impact factor: 6.047

Review 9.  Does Nonalcoholic Fatty Liver Disease Increase the Risk for Extrahepatic Malignancies?

Authors:  Somaya Albhaisi; Arun J Sanyal
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-04-13

10.  Centrilobular ductular reaction correlates with fibrosis stage and fibrosis progression in non-alcoholic steatohepatitis.

Authors:  Lei Zhao; Maria Westerhoff; Rish K Pai; Won-Tak Choi; Zu-Hua Gao; John Hart
Journal:  Mod Pathol       Date:  2017-09-01       Impact factor: 7.842
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.